Terbinafine
Sponsors
Basilea Pharmaceutica International AG Allschwil, Novartis Pharmaceuticals, Merck Sharp & Dohme LLC, Roxane Laboratories, NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences, Inc.)
Conditions
Antifungal Drugs in OnychomycosisChronic Hepatitis bFungal ResistanceFusarium spp.Invasive mold infections caused by Aspergillus spp.Lomentospora prolificansMucorales fungiOnychomycosis
Phase 1
Safety and Pharmacokinetics of Terbinafine Hydrogen Chloride (HCl) Nail Lacquer in Patients With Onychomycosis
CompletedNCT00691184
Start: 2005-02-28End: 2005-12-31Updated: 2008-06-05
Comparative Study Between Pulse Therapy With Oral Itraconazole Versus Continuous Oral Terbinafine Therapy for Treatment of Onychomycosis
CompletedNCT05578950
Start: 2022-03-01End: 2022-08-31Updated: 2022-10-19
From Fungus to Virus, Investigating the Safety and Efficacy of Terbinafine in Chronic Hepatitis B Patients
RecruitingNCT06295328
Start: 2022-04-13End: 2025-04-01Target: 36Updated: 2025-02-07
Clinical and Laboratory Evaluation of Antifungal Resistance in Tinea Capitis
Not yet recruitingNCT06400056
Start: 2024-05-31End: 2025-05-31Target: 30Updated: 2024-05-06
Phase 2
A Study to Evaluate Efficacy and Safety of Four Posaconazole Regimens With Placebo and Terbinafine in the Treatment of Toenail Onychomycosis (Study P05082AM2)(COMPLETED)
CompletedNCT00491764
Start: 2007-06-30End: 2008-12-31Updated: 2017-04-07
Trial of Antimicrobials Versus Placebo in Addition to Fecal Transplant Therapy in Ulcerative Colitis
CompletedNCT02606032
Start: 2016-05-31End: 2021-01-27Updated: 2021-02-10
Isotretinoin In Preventing Recurrences In Chronic Recurrent Dermatophytosis
NCT03471455
Start: 2018-04-30End: 2019-01-31Target: 100Updated: 2018-05-01
Terbinafine for Biochemically Recurrent Prostate Cancer (TerbinaPro)
RecruitingNCT07365423
Start: 2026-05-01End: 2030-10-01Target: 42Updated: 2026-04-02
Phase 3
Efficacy Safety, and Tolerability of Topical Terbinafine in Patients With Mild to Moderate Toenail Fungus of the Big Toenail
CompletedNCT00443820
Start: 2006-12-31End: 2008-06-30Updated: 2011-04-19
Efficacy, Safety, and Tolerability of Topical Terbinafine in Patients With Mild to Moderate Toenail Fungus of the Big Toenail
CompletedNCT00443898
Start: 2006-12-31Updated: 2012-05-03
Efficacy and Safety of Terbinafine Film Forming Solution in Patients With Tinea Pedis
CompletedNCT01433107
Start: 2011-08-31End: 2012-02-29Updated: 2013-12-27
Antifungal Drugs in Treatment of Onychomycosis
NCT03171584
Start: 2017-07-01End: 2019-11-01Target: 60Updated: 2017-05-31
An interventional Phase 3, open-label, two-cohort study to investigate the efficacy and safety of fosmanogepix in adult patients with invasive mold infections caused by Aspergillus spp., Fusarium spp., Lomentospora prolificans, Mucorales fungi, or other multidrug resistant molds
Not yet recruitingCTIS2024-516216-16-00
Target: 94Updated: 2025-12-01
Phase 4
Unknown Phase
Bioequivalency Study of Terbinafine Tablets Under Fed Conditions
CompletedNCT00602251
Start: 2004-03-31End: 2004-04-30Updated: 2018-01-23
Bioequivalency Study of Terbinafine Tablets Under Fasting Conditions
CompletedNCT00602342
Start: 2004-03-31End: 2004-04-30Updated: 2018-01-23
Efficacy Comparison of Itraconazole Pulse Therapy and Terbinafine Therapy in Treatment of Tinea Capitis in Children.
CompletedNCT07068256
Start: 2025-04-01End: 2025-09-30Updated: 2025-11-28